These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 25868999)

  • 1. The CRISPR-Cas immune system: biology, mechanisms and applications.
    Rath D; Amlinger L; Rath A; Lundgren M
    Biochimie; 2015 Oct; 117():119-28. PubMed ID: 25868999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas based targeting of host and viral genes as an antiviral strategy.
    Koujah L; Shukla D; Naqvi AR
    Semin Cell Dev Biol; 2019 Dec; 96():53-64. PubMed ID: 30953741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9-Based Antiviral Strategy: Current Status and the Potential Challenge.
    Lee C
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30959782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A short overview of CRISPR-Cas technology and its application in viral disease control.
    Ghorbani A; Hadifar S; Salari R; Izadpanah K; Burmistrz M; Afsharifar A; Eskandari MH; Niazi A; Denes CE; Neely GG
    Transgenic Res; 2021 Jun; 30(3):221-238. PubMed ID: 33830423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas Biology and Its Application to Infectious Diseases.
    Strich JR; Chertow DS
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30429256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity, evolution, and therapeutic applications of small RNAs in prokaryotic and eukaryotic immune systems.
    Cooper EL; Overstreet N
    Phys Life Rev; 2014 Mar; 11(1):113-34. PubMed ID: 24286719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity of CRISPR-Cas immune systems and molecular machines.
    Barrangou R
    Genome Biol; 2015 Nov; 16():247. PubMed ID: 26549499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parasite Exposure Drives Selective Evolution of Constitutive versus Inducible Defense.
    Westra ER; van Houte S; Oyesiku-Blakemore S; Makin B; Broniewski JM; Best A; Bondy-Denomy J; Davidson A; Boots M; Buckling A
    Curr Biol; 2015 Apr; 25(8):1043-9. PubMed ID: 25772450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memory of viral infections by CRISPR-Cas adaptive immune systems: acquisition of new information.
    Fineran PC; Charpentier E
    Virology; 2012 Dec; 434(2):202-9. PubMed ID: 23123013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paleovirology and virally derived immunity.
    Aswad A; Katzourakis A
    Trends Ecol Evol; 2012 Nov; 27(11):627-36. PubMed ID: 22901901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriophage Cooperation Suppresses CRISPR-Cas3 and Cas9 Immunity.
    Borges AL; Zhang JY; Rollins MF; Osuna BA; Wiedenheft B; Bondy-Denomy J
    Cell; 2018 Aug; 174(4):917-925.e10. PubMed ID: 30033364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas: New Tools for Genetic Manipulations from Bacterial Immunity Systems.
    Jiang W; Marraffini LA
    Annu Rev Microbiol; 2015; 69():209-28. PubMed ID: 26209264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence and Diversity of CRISPR-Cas Systems in the Genus Bifidobacterium.
    Briner AE; Lugli GA; Milani C; Duranti S; Turroni F; Gueimonde M; Margolles A; van Sinderen D; Ventura M; Barrangou R
    PLoS One; 2015; 10(7):e0133661. PubMed ID: 26230606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas systems and RNA-guided interference.
    Barrangou R
    Wiley Interdiscip Rev RNA; 2013; 4(3):267-78. PubMed ID: 23520078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic impact of CRISPR immunization against bacteriophages.
    Barrangou R; Coûté-Monvoisin AC; Stahl B; Chavichvily I; Damange F; Romero DA; Boyaval P; Fremaux C; Horvath P
    Biochem Soc Trans; 2013 Dec; 41(6):1383-91. PubMed ID: 24256225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy.
    Chen S; Yu X; Guo D
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29337866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Cmr complex: an RNA-guided endoribonuclease.
    Bailey S
    Biochem Soc Trans; 2013 Dec; 41(6):1464-7. PubMed ID: 24256238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells.
    Liao HK; Gu Y; Diaz A; Marlett J; Takahashi Y; Li M; Suzuki K; Xu R; Hishida T; Chang CJ; Esteban CR; Young J; Izpisua Belmonte JC
    Nat Commun; 2015 Mar; 6():6413. PubMed ID: 25752527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirements for a successful defence reaction by the CRISPR-Cas subtype I-B system.
    Stoll B; Maier LK; Lange SJ; Brendel J; Fischer S; Backofen R; Marchfelder A
    Biochem Soc Trans; 2013 Dec; 41(6):1444-8. PubMed ID: 24256235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolutionary causes and consequences of diversified CRISPR immune profiles in natural populations.
    England WE; Whitaker RJ
    Biochem Soc Trans; 2013 Dec; 41(6):1431-6. PubMed ID: 24256233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.